Poland seeks more flu vaccines amid shortage during pandemic

Poland’s health minister says the government is trying to secure more flu vaccines due to a national shortage fueled by higher demand during the coronavirus pandemic
Source: ABC News: Health - Category: Consumer Health News Tags: Health Source Type: news

Related Links:

If Americans were hoping to get some reassurance, clarity, or even hope from this year’s presidential candidates about how the U.S. will make it through the coronavirus pandemic, then Tuesday night’s first debate fell woefully short. During the 15-minute segment dedicated to COVID-19—which is still killing hundreds of Americans each day, and stands to worsen once again—neither President Donald Trump nor Former Vice President Joe Biden provided any substantive plans for what health experts say will be a critical next few months, and possibly years, in the fight against the coronavirus. Instead of tho...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 Source Type: news
Conclusion The use of PPE (N95 or powered air-purifying respirator [PAPR]) during procedures should be mandatory. Patients should be evaluated about their COVID-19 status before hospital admission. Cancer should be treated. Tracheostomy tube cuff should be inflated inside the tracheal incision. All COVID-19 precautions should be kept until there is a validated antiviral treatment or an available vaccine. [...] Thieme Revinter Publicações Ltda Rio de Janeiro, BrazilArticle in Thieme eJournals: Table of contents  |  Abstract  |  open access Full text
Source: International Archives of Otorhinolaryngology - Category: ENT & OMF Authors: Tags: Systematic Review Source Type: research
The ongoing outbreak of Coronavirus disease 2019 infection achieved pandemic status on March 11, 2020. As of September 8, 2020 it has caused over 890,000 mortalities world-wide. Coronaviral infections are enabled by potent immunoevasory mechanisms that target multiple aspects of innate immunity, with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) able to induce a cytokine storm, impair interferon responses, and suppress antigen presentation on both MHC class I and class II. Understanding the immune responses to SARS-CoV-2 and its immunoevasion approaches will improve our understanding of pathogenesis, virus c...
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research
Authors: Assadiasl S, Fatahi Y, Zavvar M, Nicknam MH Abstract The newly emerged severe acute respiratory syndrome-related coronavirus-2 (SARS-CoV-2) has recently caused pandemic Coronavirus Disease-2019 (COVID-19). Considering the serious medical, economic and social consequences of this pandemic and the lack of definite medication and vaccine it is necessary to describe natural immune responses to the SARS-CoV-2 in order to exploit them for treating the patients and monitoring the general population. Moreover, detecting the most immunogenic antigens of the virus is fundamental for designing effective vaccines. Ant...
Source: Human Antibodies - Category: Biochemistry Tags: Hum Antibodies Source Type: research
Despite dire warnings this summer from public health experts, over a third of U.S. colleges and universities went full steam ahead with reopening, saying they had no choice due to financial or political pressures. The results, in some instances, have been catastrophic. From August 26 to September 10, 2020, there were at least 62,000 new positive test results at U.S. colleges and universities. A recent preprint study reports that colleges that reopened for in-person instruction this fall probably contributed more than 3,000 cases daily to their counties. About half of the counties with colleges around the country reported t...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 Source Type: news
Anthony S. Fauci, MD, returns to JAMA's Q&A series to discuss the latest developments in the COVID-19 pandemic. Recorded September 25, 2020. Related Article(s): Reassuring the Public and Clinical Community About the Scientific Review and Approval of a COVID-19 Vaccine
Source: JAMA Author Interviews - Category: General Medicine Authors: Source Type: podcasts
[Monitor] Uganda is set to start human trials of the Covid-19 vaccine starting November as the country continues the fight against the pandemic, Ministry of Health officials have said.
Source: AllAfrica News: Health and Medicine - Category: African Health Source Type: news
We don ’t know yet how many of the ongoing symptoms could translate to chronic ill health in the future, and that’s worryingAs Covid-19 infection numbers show a welcome downward trend in Melbourne and the city ’s residents look forward to some easing of restrictions, it’s time to consider the longer-term health consequences of the pandemic.More than 27,000 Australians – including some 20,000 Victorians – have been infected with the virus, with almost 900 deaths to date. Many countries are now in the grip of a second wave as the pandemic continues to take a toll on millions of lives aroun...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Coronavirus outbreak Medical research Health Science Source Type: news
With an ever-climbing tally of COVID-19 infections, deaths, and calculations about how quickly the virus is spreading, the numbers can start to lose meaning. But one million is a resonant milestone. According to the Johns Hopkins Coronavirus Resource Center, the world has now lost one million lives to the new coronavirus. It’s easy to draw analogies—one million people dying of COVID-19 would be the equivalent of just over the entire population of a country like Djibouti, or just under the populace of Cyprus. Perhaps more sobering would be to think of that number less as an entity and more in terms of the precio...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 News overnight UnitedWeRise20Disaster Source Type: news
The emerging coronavirus disease (COVID-19) caused by SARS-CoV-2 has led to social and economic disruption globally. It is urgently needed to understand the structure and function of the viral proteins for understanding of the viral infection and pathogenesis and development of prophylaxis and treatment strategies. Coronavirus non-structural protein 1 (nsp1) is a notable virulence factor with versatile roles in virus-host interactions and exhibits unique characteristics on sequence, structure, and function mode. However, the roles and characteristics of SARS-CoV-2 nsp1 are currently unclear. Here, we analyze the nsp1 of SA...
Source: Frontiers in Microbiology - Category: Microbiology Source Type: research
More News: Coronavirus | COVID-19 | Government | Health | Pandemics | Poland Health | Vaccines